What is the recommended dose of ketamine (Ketamine) for maintaining sedation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ketamine Dosing for Maintaining Sedation

For maintaining procedural sedation, administer IV ketamine at 1.5-2 mg/kg as the initial dose, with additional aliquots of 0.25-0.5 mg/kg as needed to maintain adequate sedation depth throughout the procedure. 1

Initial Dosing Strategy

Intravenous Route (Preferred for Maintenance)

  • Start with 1.5-2 mg/kg IV for optimal sedation maintenance, as this dose requires significantly fewer supplemental doses compared to lower dosing 2, 1, 3
  • Only 5.5% of patients require additional ketamine when initially dosed at 1.5 mg/kg, compared to 54% requiring supplementation at 1.0 mg/kg 2, 1
  • Onset of action occurs within 30-96 seconds, allowing rapid assessment of sedation adequacy 1

Intramuscular Route (Alternative)

  • Use 4 mg/kg IM when IV access is unavailable or impractical 2, 1, 4
  • Onset occurs within 3-4 minutes 4
  • Repeat doses of 2-4 mg/kg IM may be given after 5-10 minutes if sedation is inadequate 1

Maintenance Dosing During Procedures

Supplemental Dosing Protocol

  • Administer 0.25-0.5 mg/kg IV aliquots when sedation begins to lighten during the procedure 5
  • Reassess sedation depth after each supplemental dose before administering additional ketamine 5
  • Maximum cumulative dose should not exceed 2.0 mg/kg during a single sedation session 5

Avoiding Under-Dosing

  • Starting with 1.0 mg/kg results in higher total cumulative doses (median 1.71 mg/kg) compared to starting with 1.5 mg/kg (median 1.60 mg/kg) due to frequent need for supplementation 3
  • 18.5% of patients require a third dose when starting at 1.0 mg/kg versus only 7.6% when starting at 1.5 mg/kg 3

Combination Therapy Considerations

Ketamine with Midazolam

  • Consider adding midazolam 0.05-0.1 mg/kg IV to ketamine for potentially reduced emergence reactions, though evidence is mixed on efficacy for reducing agitation 2, 1
  • The combination of 1-2 mg/kg ketamine with 0.05-0.1 mg/kg midazolam provides effective sedation with 100% procedure completion rates 2
  • For patients >10 years old, adding midazolam significantly reduces recovery agitation (5.7% vs 35.7% with ketamine alone) 2

Ketamine with Propofol

  • Low-dose ketamine (0.25-0.5 mg/kg) combined with propofol reduces total propofol requirements (0.28 vs 0.40 mg/kg/min) and shortens recovery time by 5 minutes 6

Duration and Recovery Expectations

Sedation Duration

  • Average total sedation time is approximately 75-78 minutes with IV ketamine 2
  • Recovery time averages 84 minutes (range 22-215 minutes) for IV administration 2, 1
  • IM administration results in similar recovery times of approximately 90 minutes 2

Critical Monitoring Requirements

Continuous Monitoring Mandates

  • Maintain continuous pulse oximetry, heart rate, blood pressure, and capnography (when available) throughout sedation 1, 4
  • Ensure oxygen saturation remains >93% on room air 1
  • Have bag-valve-mask ventilation equipment immediately available 4
  • Maintain IV access throughout the procedure until cardiorespiratory depression risk has resolved 7

Cardiovascular Effects

  • Expect dose-dependent increases in heart rate (18%) and blood pressure (13%) due to sympathetic stimulation 2, 1
  • New ECG ischemic changes occur in approximately 9.7% of adults >50 years, though typically without clinical significance 8

Safety Profile and Adverse Events

Common Side Effects

  • Recovery agitation occurs in 17.6% of patients (1.6% moderate-to-severe) 1, 4
  • Emesis without aspiration in 6.7% of cases 1, 4
  • Dysphoric emergence in 10-20% of cases 4

Respiratory Safety

  • Hypoxemia (SpO2 <90%) occurs in 1.6-7.3% of patients, typically transient and responsive to supplemental oxygen 2
  • Laryngospasm is rare (0.9-1.4% of cases) 4
  • Bag-valve-mask ventilation required in approximately 2% of cases 2

Absolute Contraindications

Avoid ketamine in patients with: 1, 4

  • Uncontrolled cardiovascular disease or ischemic heart disease
  • Cerebrovascular disease or uncontrolled hypertension
  • Active psychosis
  • Severe hepatic dysfunction
  • Elevated intracranial or intraocular pressure
  • Pregnancy

Key Clinical Pitfalls to Avoid

  • Do not start with 1.0 mg/kg IV thinking you'll save medication—this approach paradoxically results in higher total doses and more frequent supplementation 3
  • Do not administer supplemental doses too quickly—allow adequate time (2-3 minutes) to assess sedation depth after each dose 5
  • Do not continue ketamine infusions into the postoperative period as this increases hallucination risk without enhancing analgesia 7
  • Do not use in patients with cardiac disease without careful consideration of the sympathomimetic effects and potential for myocardial oxygen demand increase 1, 4, 8

References

Guideline

Ketamine Dosing and Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

A retrospective comparison of ketamine dosing regimens for pediatric procedural sedation.

European journal of emergency medicine : official journal of the European Society for Emergency Medicine, 2015

Guideline

Intramuscular Ketamine Dosing for Procedural Sedation in Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Low-dose ketamine: efficacy in pediatric sedation.

Pediatric emergency care, 2007

Guideline

Guidelines for Safe Administration of Ketamine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.